Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population.
about
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@ast
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@en
type
label
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@ast
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@en
prefLabel
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@ast
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@en
P2860
P1476
Efficacy and safety of JAK inh ...... sis in the Chinese population.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11684-016-0472-9
P577
2016-11-17T00:00:00Z
P6179
1020103964